BridgePoint Bio Newsletter

Do we have a plan for affordable genetic medicine?

The short answer is 'no', but we could build out this path in the next decade.

Sep 19, 2024 •

Kevin Curran

Commercial issues with gene editing

The science has turned a corner but the financial side remains murky and difficult.

Sep 5, 2024 •

Kevin Curran

Germline gene editing...might we be accidentally modifying the human lineage?

Designing a gene editing clinical trial requires a thoughtful approach towards the accidental editing of sperm and egg cells.

Jul 1, 2024 •

Kevin Curran

How can VLPs help us advance gene editing medicine?

Let's talk about Virus Like Particles... Here, I present part 3 from my video series on gene editing delivery.

Jun 17, 2024 •

Kevin Curran

How are LNPs used to deliver gene editing tools into the human body?

Crispr/Cas9 is working well...but we're still learning how to move this cargo into specific cells. (2/3)

May 21, 2024 •

Kevin Curran

How can we deliver gene editing tools into the human body?

Crispr/Cas9 is working well...but we're still learning how to move this cargo into the correct cells. (1/3)

May 7, 2024 •

Kevin Curran

How does the new gene editing drug work?

I present a short video describing how Casgevy works for Sickle Cell Disease

Apr 16, 2024 •

Kevin Curran

Watch my you tube video on gene editing challenges

I discuss a recent safety issue with base editing technology

Apr 12, 2024 •

Kevin Curran

BridgePoint Bio Newsletter

I write about advanced medicine in an approachable manner. My newsletter topics include gene editing, new strategies to cure disease and artificial intelligence in drug discovery.

About Archive Sitemap